Celyad Oncology SA (EBR:CYAD)

Celyad Oncology Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.71	4.2	7	12.45	30.02
Cash & Short-Term Investments	1.71	4.2	7	12.45	30.02
Cash Growth	-59.33%	-40.03%	-43.72%	-58.54%	74.18%
Accounts Receivable	0.75	0.8	2.72	1.12	2.06
Inventory	-	0.42	-	-	-
Other Current Assets	1.04	1.1	1.4	1.26	2.21
Total Current Assets	3.5	6.52	11.12	14.83	34.29
Net Property, Plant & Equipment	-	1.49	1.83	0.31	3.25
Other Intangible Assets	0.02	0.41	0.39	0.86	36.17
Other Long-Term Assets	0.78	1.52	2.94	3.72	6.24
Total Assets	4.3	9.93	16.28	19.72	79.94

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.51	1.23	1.24	4.75	6.61
Accrued Expenses	0.56	0.79	0.94	5.1	5.95
Current Portion of Long-Term Debt	0.62	0.64	0.37	0.44	0.36
Current Portion of Leases	-	0.14	0.16	0.14	0.9
Unearned Revenue	0.03	0.05	0.23	-	-
Other Current Liabilities	0.1	-	-	-	-
Total Current Liabilities	1.82	2.85	2.93	10.43	13.83
Long-Term Debt	-	4.2	4.51	4.58	5.85
Long-Term Leases	-	0.76	0.9	0.12	1.73
Other Long-Term Liabilities	0.04	1.61	1.64	0.27	14.9
Total Long-Term Liabilities	0.04	6.57	7.05	4.97	22.48
Total Liabilities	1.86	9.42	9.98	15.4	36.3

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	9.22	8.22	32.95	78.59	78.59
Additional Paid-in Capital	320.73	320.73	295.99	240.88	240.88
Accumulated Other Comprehensive Income	35.86	35.77	35.73	34.8	33.17
Retained Earnings	-363.37	-364.2	-358.37	-349.95	-309
Shareholders' Equity	2.44	0.51	6.3	4.32	43.64
Total Liabilities & Equity	4.3	9.93	16.28	19.72	79.94

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.62	5.74	5.93	5.28	8.85
Net Cash (Debt)	1.09	-1.54	1.08	7.17	21.17
Net Cash Growth	-	-	-85.00%	-66.14%	135.13%
Net Cash Per Share	0.03	-0.04	0.04	0.32	1.36
Book Value	2.44	0.51	6.3	4.32	43.64
Book Value Per Share	0.06	0.01	0.25	0.19	2.80
Tangible Book Value	2.42	0.11	5.91	3.45	7.47
Tangible Book Value Per Share	0.06	0.00	0.23	0.15	0.48

Data Source: Fiscal.ai Last updated: Aug 19, 2025

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 10, 2026

Data Sources Report a data error